Solum N O, Olsen T M, Gogstad G O, Hagen I, Brosstad F
Biochim Biophys Acta. 1983 Mar 23;729(1):53-61. doi: 10.1016/0005-2736(83)90455-8.
The water-soluble protein glycocalicin is generated during platelet lysis by a proteolytic attack on the integral membrane glycoprotein GP Ib. However, only small amounts of glycocalicin are formed when platelets are solubilized by 1% Triton X-100. Crossed immunoelectrophoresis of such extracts using an antiserum to glycocalicin, shows a continuous immunoprecipitate consisting of two peaks, one representing glycocalicin and the other GP Ib. When leupeptin was present during solubilization, subsequent immunoelectrophoresis revealed yet another GP Ib-related component represented by a third, slow-migrating peak of the immunoprecipitate. During incubation of platelets with dibucaine followed by solubilization in the presence of leupeptin, a gradual transformation of this new form of GP Ib into the previously defined one took place prior to the formation of glycocalicin. An increase followed by a decrease in the agglutination response of the platelets to bovine von Willebrand factor occurred concomitant with these transformations. SDS-polyacrylamide gel electrophoresis of Triton X-100 extracts of platelets did not reveal any difference in the size of GP Ib whether or not leupeptin had been present during the solubilization.
水溶性蛋白糖钙蛋白是在血小板溶解过程中,通过对整合膜糖蛋白GP Ib进行蛋白水解攻击而产生的。然而,当血小板用1% Triton X-100溶解时,仅形成少量的糖钙蛋白。使用抗糖钙蛋白抗血清对这类提取物进行交叉免疫电泳,显示出由两个峰组成的连续免疫沉淀物,一个代表糖钙蛋白,另一个代表GP Ib。当在溶解过程中存在亮抑酶肽时,随后的免疫电泳显示出另一种与GP Ib相关的成分,由免疫沉淀物的第三个慢迁移峰代表。在用丁卡因孵育血小板,随后在亮抑酶肽存在下溶解的过程中,这种新形式的GP Ib在糖钙蛋白形成之前逐渐转变为先前定义的形式。血小板对牛血管性血友病因子的凝集反应先增加后减少,这些转变同时发生。血小板的Triton X-100提取物的SDS-聚丙烯酰胺凝胶电泳未显示出在溶解过程中是否存在亮抑酶肽时GP Ib大小有任何差异。